-
1
-
-
17444372975
-
-
Theta Reports. 53. 59-61 (1998)
-
(1998)
Theta Reports
, vol.53
, pp. 59-61
-
-
-
2
-
-
0037306738
-
The product market and the market for "ideas" commercialization strategies for technology entrepreneurs
-
D.O. Joshua & Scott S.: The product market and the market for "ideas" commercialization strategies for technology entrepreneurs. Research Policy 32, 333-350 (2003)
-
(2003)
Research Policy
, vol.32
, pp. 333-350
-
-
Joshua, D.O.1
Scott, S.2
-
3
-
-
17444369989
-
-
W. Lauara: http://www.researchandmarkets.com/reports/c1584 (2004)
-
(2004)
-
-
Lauara, W.1
-
5
-
-
17444364701
-
Green genes: Agricultural biotechnology
-
Eds: A. Tom, Henry Holt and Company Press, NY
-
A. Tom: Green genes: agricultural biotechnology. In: The biotech investor. Eds: A. Tom, Henry Holt and Company Press, NY (2003)
-
(2003)
The Biotech Investor
-
-
Tom, A.1
-
7
-
-
17444366413
-
Developing new products
-
Eds: P. Kotler, Prentice Hall Press, Singapore
-
P. Kotler, Ang, S.H., Leong, S. M. & Tan, C. T.: Developing new products. In: Marketing management. Eds: P. Kotler, Prentice Hall Press, Singapore (1999)
-
(1999)
Marketing Management
-
-
Kotler, P.1
Ang, S.H.2
Leong, S.M.3
Tan, C.T.4
-
8
-
-
17444414073
-
Six keys to commercialization
-
D. E. Olesen: Six keys to commercialization. EMR, Summer, 59-62 (1991)
-
(1991)
EMR
, vol.SUMMER
, pp. 59-62
-
-
Olesen, D.E.1
-
9
-
-
0003107957
-
Stage-Gate System: A new tool for managing new products
-
R. G. Cooper: Stage-Gate System: A new tool for managing new products, Business Horizons, 44-54 (1990)
-
(1990)
Business Horizons
, pp. 44-54
-
-
Cooper, R.G.1
-
11
-
-
17444384013
-
From mind to market: The process of technology commercialization
-
Harvard Business School Press, Boston, Massachusetts
-
V. K. Jolly: from mind to market: the process of technology commercialization. In:Commercializing new technology: Getting from mind to market. Harvard Business School Press, Boston, Massachusetts (1997)
-
(1997)
Commercializing New Technology: Getting from Mind to Market
-
-
Jolly, V.K.1
-
12
-
-
17444420550
-
-
Market assessment of Global biomaterials and diagnostics industries, Strategic Analysis Inc. Press
-
Report to chemical industries federation of Finland, Market assessment of Global biomaterials and diagnostics industries, Strategic Analysis Inc. Press (2002)
-
(2002)
Report to Chemical Industries Federation of Finland
-
-
-
13
-
-
0242636032
-
A. Entrepreneurs' Choice of entry strategy in emerging and developed market
-
M. Levesque, & Shepherd D.: A. Entrepreneurs' Choice of entry strategy in emerging and developed market. J of Business Venturing 19. 1, 29-54 (2004)
-
(2004)
J of Business Venturing
, vol.19
, Issue.1
, pp. 29-54
-
-
Levesque, M.1
Shepherd, D.2
-
14
-
-
84989092786
-
Evaluating Technological Collaborative Opportunities: A cognitive modeling perspective
-
B. B. Tyler: Evaluating Technological Collaborative Opportunities: A cognitive modeling perspective. Strategic management J 16, 43-70 (1995)
-
(1995)
Strategic Management J
, vol.16
, pp. 43-70
-
-
Tyler, B.B.1
-
15
-
-
17444366794
-
Make-or-Buy decisions in R&D: Small technology based firms in the United States and Japan
-
EM-29.1
-
S. Kurokawa: Make-or-Buy decisions in R&D: small technology based firms in the United States and Japan. IEEE management. EM-29.1, 28-45 (1997)
-
(1997)
IEEE Management
, pp. 28-45
-
-
Kurokawa, S.1
-
17
-
-
38549086633
-
Profiting from technological innovation: Implications for integration, collaboration, licensing, and public policy
-
D.J. Teece: Profiting from technological innovation: implications for integration, collaboration, licensing, and public policy. Research Policy 15, 285-305 (1986)
-
(1986)
Research Policy
, vol.15
, pp. 285-305
-
-
Teece, D.J.1
-
18
-
-
0035478657
-
Complementary assets, strategic alliances, and the incumbent's advantage: An empirical study of industry and firm effects in the biopharmaceutical industry
-
F. T. Rothaermel: Complementary assets, strategic alliances, and the incumbent's advantage: an empirical study of industry and firm effects in the biopharmaceutical industry. Research Policy 30, 1235-1251 (2001)
-
(2001)
Research Policy
, vol.30
, pp. 1235-1251
-
-
Rothaermel, F.T.1
|